Works in Cancer Chemotherapy & Pharmacology, 2016, Vol 77, Issue 5
Results: 23
The druggability of intracellular nucleotide-degrading enzymes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The selective estrogen receptor modulators in breast cancer prevention.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The anti-angiogenic effect of dexamethasone in a murine hepatocellular carcinoma model by augmentation of gluconeogenesis pathway in malignant cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.
- Published in:
- 2016
- By:
- Publication type:
- journal article